Page last updated: 2024-11-03

riluzole and Catatonic Rigidity

riluzole has been researched along with Catatonic Rigidity in 1 studies

Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.

Research Excerpts

ExcerptRelevanceReference
"Riluzole pretreatment induced a persistent increase in dopamine turnover when compared to MPTP alone."1.29Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: a pilot study. ( Benazzouz, A; Boireau, A; Boraud, T; Dubédat, P; Gross, C; Stutzmann, JM, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benazzouz, A1
Boraud, T1
Dubédat, P1
Boireau, A1
Stutzmann, JM1
Gross, C1

Other Studies

1 other study available for riluzole and Catatonic Rigidity

ArticleYear
Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: a pilot study.
    European journal of pharmacology, 1995, Sep-25, Volume: 284, Issue:3

    Topics: Animals; Antiparkinson Agents; Dopamine; Electromyography; Excitatory Amino Acid Antagonists; Macaca

1995